Investor Relations
Healthcare Excellence by the Numbers
Partner With Us
Explore diversified investment opportunities across Liyana Healthcare's six strategic sectors.
Healthcare Facility Expansion
Investment in new diagnostic centers and specialized clinics across Ethiopia
Min. investment
ETB 27M
Expected return
14-18% annually
Timeline
5-7 years
Key sectors
Pharmaceutical Manufacturing
Expansion of pharmaceutical production capabilities and distribution network
Min. investment
ETB 50M
Expected return
16-20% annually
Timeline
4-6 years
Key sectors
Medical Education & Research
Investment in medical education facilities and research infrastructure
Min. investment
ETB 35M
Expected return
10-14% annually
Timeline
7-10 years
Key sectors
Financial Performance
Transparent reporting on our financial results, strategic achievements, and operational milestones.
Annual Financial Report 2024
Revenue
ETB 2.1B
Growth
+23% YoY
File size
3.2 MB
Key highlights
- Opened 2 new diagnostic centers
- ISO recertification achieved
- Patient satisfaction increased to 89.1%
Annual Financial Report 2023
Revenue
ETB 1.7B
Growth
+18% YoY
File size
2.8 MB
Key highlights
- Launched pharmaceutical division
- Expanded to 9 operational facilities
- Achieved profitability milestone
Strong Fiscal Performance
Year-over-year growth across all key financial indicators demonstrates our sustainable business model.
Fiscal Year 2024
Our Roadmap
Strategic initiatives driving growth, innovation, and sustainable healthcare transformation.
Regional Healthcare Network Expansion
Establish 5 new diagnostic centers in underserved regions across Ethiopia
Expected impact
30% increase in patient accessibility
Key milestones
- Site selection and feasibility studies (Q1 2025)
- Construction and equipment procurement (2025-2026)
- Staff recruitment and training (Q4 2026)
- Grand opening and operations launch (Q1 2027)
Digital Health Technology Integration
Implement comprehensive EMR system and telemedicine capabilities
Expected impact
50% reduction in administrative overhead
Key milestones
- EMR system vendor selection (Completed)
- Pilot implementation in 3 facilities (Q2 2025)
- Full rollout across all facilities (Q4 2025)
- Telemedicine platform launch (Q2 2026)
Quality Excellence Program
Maintain ISO certifications and pursue international accreditation
Expected impact
International accreditation achievement
Key milestones
- ISO recertification (Completed)
- JCI accreditation preparation (2025-2026)
- International peer review (2027)
- JCI accreditation achievement (2028)
Environmental Sustainability Initiative
Reduce carbon footprint and implement green energy solutions
Expected impact
50% reduction in carbon emissions
Key milestones
- Baseline carbon audit (Q2 2025)
- Solar energy installation in 3 facilities (2026)
- Waste management optimization (2027-2028)
- Carbon neutrality target (2030)
Resource Hub
Access reports, presentations, governance documents, and media materials.
Annual Financial Report 2024
Annual Financial Report 2023
Q4 2024 Quarterly Report
Investor Presentation Q4 2024
Comprehensive overview of performance and strategy
Strategic Overview 2025-2028
Corporate Governance Framework
ISO 9001:2015 Certifications
Liyana Brand Guidelines
Speak With Investor Relations
Whether you are an individual, institution, or strategic partner, our Investor Relations team can share detailed materials and arrange a confidential conversation about opportunities across the Liyana ecosystem.
Diversified across 6 sectors
Access opportunities spanning clinical services, diagnostics, pharma, financing, education and digital health.
Governance you can trust
ISO 9001:2015 certified operations with transparent reporting and a formal governance framework.
A confidential process
Detailed data rooms and briefings shared privately once your interest is registered.
Direct line
investors@liyana.comResponse time
Within 2 business days
